Bis(3,5-dibromosalicyl) Fumarate - CAS 71337-53-6
Catalog: |
BB034359 |
Product Name: |
Bis(3,5-dibromosalicyl) Fumarate |
CAS: |
71337-53-6 |
Synonyms: |
3,5-dibromo-2-[(E)-4-(2,4-dibromo-6-carboxyphenoxy)-1,4-dioxobut-2-enoxy]benzoic acid; 3,5-dibromo-2-[(E)-4-(2,4-dibromo-6-carboxyphenoxy)-4-oxobut-2-enoyl]oxybenzoic acid |
IUPAC Name: | 3,5-dibromo-2-[(E)-4-(2,4-dibromo-6-carboxyphenoxy)-4-oxobut-2-enoyl]oxybenzoic acid |
Description: | Bis(3,5-dibromosalicyl) Fumarate (CAS# 71337-53-6 ) is a useful research chemical. |
Molecular Weight: | 671.87 |
Molecular Formula: | C18H8Br4O8 |
Canonical SMILES: | C1=C(C=C(C(=C1Br)OC(=O)C=CC(=O)OC2=C(C=C(C=C2C(=O)O)Br)Br)C(=O)O)Br |
InChI: | InChI=1S/C18H8Br4O8/c19-7-3-9(17(25)26)15(11(21)5-7)29-13(23)1-2-14(24)30-16-10(18(27)28)4-8(20)6-12(16)22/h1-6H,(H,25,26)(H,27,28)/b2-1+ |
InChI Key: | INZBQWPDNWVYFR-OWOJBTEDSA-N |
Boiling Point: | 726.1 ℃ at 760 mmHg |
Density: | 2.174 g/cm3 |
LogP: | 5.49060 |
Publication Number | Title | Priority Date |
CN-112852772-A | Urate oxidase based on intramolecular cross-linking and polyethylene glycol modification and preparation method thereof | 20210119 |
US-2021015935-A1 | Hemoglobin-based therapeutic agents | 20190719 |
WO-2021013131-A1 | Hemoglobin-based therapeutic agents | 20190719 |
US-2020172512-A1 | Chemical Compounds | 20181129 |
WO-2020109994-A1 | Pyrazoles as modulators of hemoglobin | 20181129 |
PMID | Publication Date | Title | Journal |
18437592 | 20080101 | DBBF modified human placenta hemoglobin through the alpha chains | Artificial cells, blood substitutes, and immobilization biotechnology |
16848758 | 20061101 | Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo | The Biochemical journal |
15327368 | 20040801 | Chemically modified porcine hemoglobins and their biological properties | Protein and peptide letters |
15236579 | 20040713 | Crystal structures of unliganded and half-liganded human hemoglobin derivatives cross-linked between Lys 82beta1 and Lys 82beta2 | Biochemistry |
14965484 | 20040301 | Overcoming blood shortages: red blood cell and platelet substitutes and membrane modifications | Current hematology reports |
Complexity: | 656 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 1 |
Exact Mass: | 671.69117 |
Formal Charge: | 0 |
Heavy Atom Count: | 30 |
Hydrogen Bond Acceptor Count: | 8 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 667.69527 |
Rotatable Bond Count: | 8 |
Topological Polar Surface Area: | 127 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 5.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS